Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-10 @ 3:04 PM
Study NCT ID:
NCT02810951
Status:
TERMINATED
Last Update Posted:
2023-02-08
First Post:
2016-06-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Sponsor:
Castle Creek Biosciences, LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-13
First Submit QC Date:
None
Study First Post Date:
2016-06-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-07-23
Results First Submit QC Date:
None
Results First Post Date:
2021-09-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-06
Last Update Post Date:
2023-02-08
Last Update Post Date Type:
ACTUAL